1737 — Taiyen Biotech Co Share Price
0.000.00%
Last trade - 00:00- TWD6.33bn
- TWD4.60bn
- TWD3.24bn
- 82
- 58
- 35
- 64
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.95 | ||
| Price to Tang. Book | 0.95 | ||
| Price to Free Cashflow | 17.96 | ||
| Price to Sales | 1.95 | ||
| EV to EBITDA | 8.31 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.82% | ||
| Return on Equity | 5.65% | ||
| Operating Margin | 10.75% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 3,130.35 | 4,095.65 | 3,613.61 | 3,408.81 | 3,238.15 | n/a | n/a | 2.18% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +5.91 | +8.14 | +8.8 | -29.61 | +23.96 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Taiyen Biotech Co Ltd is a Taiwan-based company mainly engaged in provision of salt products, bottled water, cosmetics, cleaning products, health foods and other products. The Company's main products include natural salt for industry, agriculture, food processing and fisheries; coarse grained salt, which is mainly used as a raw material for the production of titanium dioxide; iodized high quality salt for cooking, pickling and soaking fruits and vegetables; refined salt for industry, agriculture and food processing; dietary low-sodium for cooking and seasoning; bottled water for general drinking water; cosmetics for daily skin care, moisturizing, anti-aging, whitening and sun protection; cleaning products for daily cleaning, bath products and toothpaste; health food for daily body health; snacks; medical devices for wound dressings; and fermented products for health products, cleaning products and beauty care products. The products are mainly sold in Taiwan and mainland China.
Directors
- Jung-Hui Wu CHM
- Shi-Hui Chen GMG
- Wei Su OTH
- Kuan-Ping Chen DRC
- Hsien-Kuei Liao DRC
- Ya-Chuan Liu DRC
- Wen-Sheng Tseng DRC
- Ching-Tien Wang DRC
- Chien-Lung Chan IND
- Shun-Tien Huang IND
- Ying-Man Kuo IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 1st, 1995
- Public Since
- November 18th, 2003
- No. of Employees
- 487
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 200,000,000
- Address
- No. 297, Section 1, TAINAN, 702
- Web
- https://www.tybio.com.tw/
- Phone
- +886 62160688
- Contact
- Chieh-Han Li
- Auditors
- Ernst & Young LLP
Upcoming Events for 1737
Taiyen Biotech Co Ltd Annual Shareholders Meeting
Q2 2025 Taiyen Biotech Co Ltd Earnings Release
Similar to 1737
AGV Products
Taiwan Stock Exchange
Charoen Pokphand Enterprise Taiwan Co
Taiwan Stock Exchange
Dawushan Farm Technology Co
Taiwan Stock Exchange
Formosa Oilseed Processing Co
Taiwan Stock Exchange
Fwusow Industry Co
Taiwan Stock Exchange
FAQ
What is the Taiyen Biotech Co share price?
As of Today at 23:33 UTC, shares in Taiyen Biotech Co are trading at TWD31.65. This share price information is delayed by 15 minutes.
How has the Taiyen Biotech Co share price performed this year?
Shares in Taiyen Biotech Co last closed at TWD31.65 and the price had moved by -6.5% over the past 365 days. In terms of relative price strength the Taiyen Biotech Co share price has underperformed the FTSE Developed Asia Pacific Index by -5.43% over the past year.
What are the analyst and broker recommendations for Taiyen Biotech Co?
There is no consensus recommendation for this security.
Find out moreWhat is the Taiyen Biotech Co dividend yield?
The Taiyen Biotech Co dividend yield is 4.11% based on the trailing twelve month period.
Does Taiyen Biotech Co pay a dividend?
Last year, Taiyen Biotech Co paid a total dividend of TWD1.30, and it currently has a trailing dividend yield of 4.11%. We do not have any data on when Taiyen Biotech Co is to next pay dividends.
When does Taiyen Biotech Co next pay dividends?
We do not have data on when Taiyen Biotech Co is to next pay dividends. The historic dividend yield on Taiyen Biotech Co shares is currently 4.11%.
How do I buy Taiyen Biotech Co shares?
To buy shares in Taiyen Biotech Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Taiyen Biotech Co?
As of the previous close price of TWD31.65, shares in Taiyen Biotech Co had a market capitalisation of TWD6.33bn.
Where are Taiyen Biotech Co shares listed?
Here are the trading details for Taiyen Biotech Co:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 1737
What kind of share is Taiyen Biotech Co?
Based on an overall assessment of its quality, value and momentum Taiyen Biotech Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Taiyen Biotech Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Taiyen Biotech Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Taiyen Biotech Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +0.26%.
As of the last closing price of TWD31.65, shares in Taiyen Biotech Co were trading -4.45% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Taiyen Biotech Co PE Ratio?
The Taiyen Biotech Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD31.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Taiyen Biotech Co?
Taiyen Biotech Co's management team is headed by:
- Jung-Hui Wu - CHM
- Shi-Hui Chen - GMG
- Wei Su - OTH
- Kuan-Ping Chen - DRC
- Hsien-Kuei Liao - DRC
- Ya-Chuan Liu - DRC
- Wen-Sheng Tseng - DRC
- Ching-Tien Wang - DRC
- Chien-Lung Chan - IND
- Shun-Tien Huang - IND
- Ying-Man Kuo - IND